Skip to content
The Policy VaultThe Policy Vault

Symlin (pramlintide) — Medica

Type 1 diabetes mellitus

Initial criteria

  • Patient has type 1 or type 2 diabetes mellitus
  • Symlin is prescribed as an adjunct to insulin therapy

Approval duration

3 years